Akèy › Skleroderm Difize › Illinois › Chicago
Etid klinik pou Skleroderm Difize nan Chicago, IL
7 etid pou Skleroderm Difize ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Ap rekriteFaz 2
- University of Chicago Hospitals, Chicago
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- The University of Chicago Medical Center, Chicago
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Ap rekriteFaz 2/3
- GSK Investigational Site, Chicago
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Ap rekriteFaz 1
- Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- The University of Chicago Medical Center (UCMC), Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Ap rekriteFaz 2/3
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Ap rekriteFaz 1/2
- Nkarta Investigational Site, Chicago
Etid Skleroderm Difize nan lòt vil
- New York City, NY8 etid
- Ann Arbor, MI7 etid
- Durham, NC6 etid
- Los Angeles, CA6 etid
- Houston, TX5 etid
- Boston, MA5 etid
- Baltimore, MD5 etid
- Kansas City, KS4 etid
- Philadelphia, PA4 etid
- New Orleans, LA4 etid
- Pittsburgh, PA4 etid
- Dallas, TX3 etid
Lòt etid nan Chicago
- Kansè Poumon ki pa ti selil61 etid
- Kansè nan tete58 etid
- Kansè (tout kalite)52 etid
- Kansè Metastatik45 etid
- Kansè pwostat45 etid
- Obèsite42 etid
- Kansè poumon41 etid
- Kansè ovè36 etid
- Akidan serebavaskilè34 etid
- Ensifizyans kadyak32 etid
- Kansè kolorektal32 etid
- Sipwa28 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.